Trial Profile
A Phase-I Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Escalating Oral Doses of GRT0151Y in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Axomadol (Primary)
- Indications Acute pain
- Focus Adverse reactions
- Sponsors Grunenthal
- 11 Dec 2018 New trial record